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Pillemer and  coworkers have  demonstrated  two  consecutive steps  in  the 
reaction between properdin,  zymosan,  and  the  third  component of comple- 
ment (C'3). First, the formation of a complex between properdin and zymosan; 
second, the reaction of the complex with C'3 (1, 2). In the first paper of this 
series  (3),  quantitative methods for the determination of human  C'3 based, 
to a  large extent, on ideas developed by Mayer and coworkers in studies of 
guinea pig C'  (4), were applied to a  study of the kinetics of the over-all re- 
action between properdin, zymosan, and  C'3.  In  this paper,  kinetic data on 
the reaction of properdin with zymosan will be presented. 
Nomendalure 
The following  abbreviations will  be used:-- 
Human complement  HuC' 
The four recognized components of  C'1, C'2, C'3,  C~4 
C' 
EA 
EAhuC'A 
Properdin 
Zymosan 
Properdin-zymosan complex 
RP 
R3 
Na~E.D.T.A. 
EAg.p.C'I,  4,  s 
Sensitized sheep cells 
The  complex  between  EA  and  what  are 
believed  to be  C'I,  C'2  and  C'4 of HuC' 
P 
Z 
PZ 
Serum lacking properdin 
Serum lacking properdin and C'3 
Trisodium ethylene-diaminetetraacetic acid 
The complex between EA and  C'1,  C'4 and 
C'2 of guinea pig C' 
Materials and Methods 
HuC'.--The  pooled serum from healthy  human donors was distributed in small vials 
and kept frozen at -60°C. 
* This work was supported by The Prentiss Foundation and the National Institutes  of 
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EA.--Sheep cells preserved with NasE.D.T.A. and penicillin (5)  were standardized  and 
sensitized by the method  described in reference 6. 
Buger.--Veronal buffer (7) cont~n~ng 0.0001S ~  Ca  ++ and 0.0005  ~  Mg++ was used for 
all dilutions and washings except where noted, 
E.D.T.A.  buffer.--Veronal  buffer,  0.008  ~r  in  NaaE.D.T.A.  was used  to bind  divalent 
cations. 
Zymosan.--Prepamtion 5B1711 was used throughout  this work and was activated before 
use as described in (8). 
EAhuC'a.--The EAhuC~ complex (9), was prepared either by addition of 20.0 ml. of a 
sublytie dilution of huC', usually huCP/100,  or in later work, of R3/20 to a mixture of 40.0 
ml. of EA and 40.0 ml. of buffer at 37°C. After 1 to 3 minutes, 2 volumes of chilled saline 
were added, the mixture was rapidly cooled to 4-6°C. and 15.0 ml. aliquots of this standard 
suspension  of EAhuC'A were added  to chilled tubes.  After centrifugation in the  cold,  the 
supernatants  were poured  off,  the tubes were wiped with  filter paper,  and  the EAhuC'x 
button broken up by tapping the tubes with the fingers.  Once formed, EAhuC~A deteriorates 
rapidly unless precautions are taken to maintain the temperature at 4-6°C. Lysis of EAhuC~A 
was carried out at 32°C. (10) for 1 hour. 
RP.--Pooled human serum, from which the properdin had  been absorbed by treatment 
with zymosan at  15°C. and  then twice at 37°C., was the source of RP. Each batch of RP 
was then tested for loss of C~3 on incubation with fresh zymosan at 37°C. Only RP showing 
no loss of C'3 within the limits of error of the experimental method was used. 
R3.--Human  serum, diluted  1 ~  2 was shaken  for one hour at 37°C. with 2.5  rag.  of 
zymosau per ml. After centrifugation the R3 was frozen at -60°C. This type of preparation 
is an R3 only in the sense that it lacks C~3 and can form EAhuC% It may not meet the 
criteria set up for R3 in reference (11). 
Kinetic Technique.--All reactions were carried out in baths controlled to =k0.1°C. Mixing 
was accomplished by using a wrist action shaker. Pipettes cooled in cold buffer were used in 
all experiments carried out below room temperature. 
EXPEP I~rENTAL 
Rate of Inactivation of Ct3 by Two Preparations  of Zymosan.--PiUemer and 
coworkers  (12)  have  shown  that  zymosans  vary  widely  in  their  activity. 
Therefore,  the activity  of  5B171  was  compared  with  that  of  preparation 
LE-1,  ~ used  in  the  earlier  work  (3). 
5.0 ml. portions of serum were shaken with 10 rag.  of LEA or 10 rag. of 5B171  at 32°C. 
0.5 ml. samples were withdrawn at intervals, added to 1.0 ml. cold buffer, mixed and cen- 
trifuged immediately. The supernatants  were diluted 1 --* I1  using cold E.D.T.A.  buffer. 
3.5  ml. portions of these dilutions were added  to packed  EAhuC% mixed, stoppered  and 
incubated  at 32°C.  for 1 hour. 
The results,  plotted in Fig.  1,  show  that LE-1  and 5B171  remove C'3 from 
serum  at  about  the  same rate. 
E~ect of E.D.T.A. on tke Reaction of Zymosan with Properdin.-- 
At 15°C. 5.0 ml. portions of human serum were mixed with Na~E.D.T.A. and  5B171  as 
shown in Table I. 0.5 ml. aliquots were removed at intervals and  pipetted into 6.0 ml. of ice 
cold E.D.T.A.  buffer.  The mixtures  were centrifuged and  washed  once with saline in the 
1 Purchased from Standard  Brands,  Inc. 
Kindly supplied by Dr. L. Pillemer. MYRON  A.  LEON  405 
cold, to remove residual serum and E.D.T.A.  The precipitates were  broken up  by tapping, 
and analyzed for reactivity towards  C'3 as follows:  1.0 ml. of RP/4.5  was  added  to each 
tul-e and the suspension incubated, with shaking, at 37°C. for 1 hour. The tubes were chilled 
and mixed with 6.0 ml. portions of cold E.D.T.A.  buffer. The  residual C'3 was determined 
by adding 4.0 ml. aliquots to packed EAhuC'A. The mixtures were stoppered and incubated 
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FZG. 1.  Inactivation of C'31'by zymosans LE-1, ~, and 5B171, (D. 
at 32°C.  for 1 hour. A  blank,  consisting of 4.0 ml. of E.D.T.A.  buffer plus EAhuC~ was 
run concurrently. 
While E.D.T.A. stops the formation of PZ, (cL Fig. 2), there may be some 
dissociation of  the  complex at  15°C. in the presence of E.D.T.A.  Attempts 
are now being made to isolate properdin from PZ using E.D.T.A. 
The Stability  of PZ  in  CoZd E.D.T.A.  Bullet. m 
Two 3.5 ml. aliquots of serum were incubated with 7 rag. portions of 5B171. After 26.4 
minutes and 36.0 minutes respectively, at 15°C.,  36 ml. of cold E.D.T.A. buffer were added. 0.650 
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Fzo. 2.  Effect of E.D.T.A.  on the reaction of zymosan with properdin; O, no E.D.T.A.; 
[], E.D.T.A.  added at 12.8 minutes; A, E.D.T.A. added at 36.3 minutes. 
TABLE  I 
Effect  ~  Na~.D.T.A.  ~  t~  Re~gon  ~  Zymosan  ~thProp~dm 
Serum  5B171" 
ml.  ml. 
A  5.0  0.5 
B  5.0  0.5 
C  5.0  0.5 
$~BIH 
m/n. 
2.5 
2.8 
14.3 
NatE.D.T.A.§ 
ml. 
0.5 
0.5 
tE.D.T.A.  Sample  E.D.T.A. 
volume  buffer 
rain.  ral.  ral. 
0.5  6.0 
12.8  0.5  6.0 
36.3  0.5  6.0 
* 20 mg./ml. 
t, time of addition. 
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Aliquots measuring 6.0 ml. were pipetted into cold test tubes. At approximately 15 minute 
intervals, a  tube of each series was centrifuged in the cold,  washed with cold  saline, and 
tested for activity towards CI3. 
The results (cf. Table 1-I) show that no significant dissociation of PZ occurs 
in 75 minutes at 0°C. 
TABLE  II 
Stability of PZ in Cold E.D.T.A.  Buffer 
T sample  Optical density* 
mln. 
0 
15 
30 
45 
6O 
75 
0.511 
0.482 
O. 530 
O. 475 
O. 488 
O. 480 
0.045 
0.092 
0.040 
0.058 
0.065 
* The optical density found with RP unabsorbed by PZ was 0.780. 
TABLE  HI 
Tke Stabilitymof Human C'3 in E.D.T.A.  Buffer 
Sample 
Optical density 
Fresh sample  24 hr. sample 
0.270 
0.242 
0.139 
0.073 
0.048 
0.257 
0.225 
0.126 
0.074 
0.030 
Stability  of Human C'3 in E.D.T.A.  Bul~er.--It  became  apparent in pre- 
liminary experiments  on the formation of PZ that considerable  economy in 
time and effort would result from doing the kinetic experiments  one day and 
analyzing for residual  C'3,  (using  EAhuC'A),  the next. Accordingly,  an  ex- 
periment was  set up  to determine the stability of human C'3  in  E.D.T.A. 
buffer. 
4.0 ml. aliquots of a  series of dilutions of human serum in E.D.T.A.  buffer, (from an ex- 
periment on the formation of PZ), were added to packed EAhuC'A and the mixtures incu- 
bated at 32°C. for 1 hour. The dilutions were reserved in the cold room for 24 hours for a 
repeat  of the experiment, using fresh EAhuC'A. 408  PEOPERDIN-COM?L~.M~.NT SYSTEm. lI 
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Fro. 3.  Lysis of EAhuC~, formed with R3/20,  (9; huC'/100, A. 
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FIG. 4.  Effect of varying serum concentration on the reaction of properdin with zymosan; 
O, undiluted; &, 1 ~  2; x~7, 1 ~  4; X, 1 --* 8. m'~aON A.  LEON  409 
The data are presented in Table III, and indicate that human C'3 is stable 
for 24 hours at 4°C. 
Lysis of EAhuC'a Formed with R3.--In  the preparation of RP  by absorp- 
tion with zymosan at both 15°C. and 37°C., a//~ to ~  of the total C'3 is usually 
lost.  This necessitated increasing the sensitivity of the test for C'3  and was 
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FIG. 5. Effect of varying concentrations of zymosan on the reaction of zymosan with 
properdin; X, 1.8 mg./ml.; •,  0.91 mg./ml.; &, 0.46 mg./ml.; Q, 0.23 mg./ml. 
accomplished by substitution  of R3  for whole  serum  in  forming EAhuC'A. 
R3 contains most of the huC'x in serum (9), and dilutions of R3/10 or R3/20 
could be used as routine to  prepare EAhuC'A,  whereas whole serum usually 
had to be diluted to ~0  to avoid large blanks.  The lysis obtained by using 
R3 to form EAhuC'A is compared with that obtained with huC'/75 in  Fig. 3. 
The experiment followed the technique described in reference (9). 
Effect  of  Varying  Serum  Concentration  on  tie  Reaction  of  Zymosan  with 
Properdin.  N 410  PROPERDIN-C0~LPLEM~NT  SYSTEM',  II 
At 15°C., 0.5 ml. of 5B171 (20 mg./ml.) were added to 4.5 ml. of varying dilutions of 
human serum.  0.5 ml. aliquots were removed  at intervals and pipetted into 6.0 ml.  of ice 
cold E.D.T.A.  buffer.  The mixtures were  analyzed for reactivity with  C'3 as usual. 
This  experiment  measures  the rate of  formation of a  complex  capable of 
inactivating C'3.  The  quantity of C'3  inactivated is directly proportional  to 
the quantity of complex (3). The data, plotted in Fig. 4,  showed an increase 
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FIO. 6.  Effect of temperature on the reaction of properdin with zymosan; A, 5°C.; @, 10°C. 
in the rate of formation of the complex with time, an indication that  the re- 
action of properdin with zymosan was complex. The same type of curve was 
obtained  when  zymosan LE-1  was  substituted  for  5B171,  and  when  bovine 
or pig serum  was substituted for human  serum. 
Effect  of  Varying  Concentrations of Zymosan  on the Reaction  of Properdin 
with Zymosan.-- 
0.5 ml.  of varying concentrations  of 5B171 were added to 5.0 ml.  portions of  serum/2 
at 15°C. Sampling and testing for the formation of PZ were carried out as described in the 
previous experiment.  The results are shown  in  Fig. 5. MYRON A. LEON  411 
The  kinetics  of  the  reaction  are  seen  to  be  markedly  dependent  on  the 
concentration of zymosan. An induction period is noted only with the highest 
concentration of zymosan (2 mg./ml.). 
E~ect of Temperature  on the Reaction  of Properdin with Zymosan.-- 
5.0 ml. portions of human serum, diluted 1 ~  2, were incubated with 0.5 ml. of 5B171 
(20 mg./ml.)  at  100C. and 5°C.  Sampling and determination of the rate  of formation of 
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Fro. 7.  Effect of pH on the reaction of properdin with zymosan; X, tris buffer final pH 
8.1; A, tris buffer final pH 7.6; (D, veronal buffer final pH 7.6; rZl, acetate buffer final pH 6.2. 
All buffers contained 5 X  10  -4 ~ Mg  ++, and 5 X  10--  ~ ~ NaC1 in a final molarity of 0.15. 
complex capable of reacting with C'3 was carried out as usual. The results are shown in 
Fig. 6. 
While  active  complex  was  formed  at  10°C.,  none was  detected  at  5°C.  It 
is, of course, possible that the induction period at 5°C. is longer than the time 
of the experiment? 
Effecl  of pH on the Reaction  of Properdin with Zymosan.-- 
Mixtures of serum with equal volumes of various buffers  were made.  The experiment 
was run at 15°C., using 5.0 ml. aliquots of the diluted sera and 10 rag.  of 5B171. The data 
are graphed in Fig. 7. 
3 In recent experiments, PZ was formed from either human or bovine serum after stirring 
for 18 hours at 4°C. 412  PROPEI~DIN-COMPLEMENT  SYSTEM, II 
The experiments described in this section used relatively large volumes of 
triply absorbed  RP,  a  reagent which is both expensive and difficult to pre- 
pare. Since the sole function of the RP was to provide C'3, a more convenient 
source of this  component was sought. The following experiments were  con- 
ducted with a  pig fraction containing C'I,  C'3, and C'4 (5). 
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Flo. 8.  Effect of varying amounts of 1,3,4 fraction on a constant quantity of EAg.p.C'x, 4, 2. 
Stoi~hiometry of the Reaction between EA g.p. Cti.4~ and tke 1,3,4 Frcxtion.-- 
The complex between EA and  C'I, Ct4,  and  C'2 of guinea pig C' (EAg.p.C'I. 4, ?)  was 
prepared using a  sublytie amount of guinea pig C' at 27°C.  (13). The reaction was  stopped 
by the addition of 2 volumes of ice cold saline. From this point on, the procedure followed 
that given in Materials and Methods for EAhuC'A. 4.0 ml. of varying dilutions of two dif- 
ferent preparations  of the  1,3,4  fraction in  E.D.T.A.  buffer  (to suppress  reaction  of  the 
C'I  and  C'4)  were added,  and  the mixtures incubated  at 32"C. for  1 hour. MYRON  A.  LEON  413 
A  direct proportionality between  the  amount  of  1,3,4  added and  the  re- 
sultant optical density was found over a  wide range of 1,3,4  concentrations 
(Fig. 8). 
Comparison  of Reactivity  of 1,3,4 Fraction  and RP with PZ.-- 
Dupficate flasks were set up at 15°C., containing 5.0 ml. of human serum/2 and 10 rag. 
of 5B171. Aliquots were removed at intervals and assayed for PZ content, using either RP 
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FIG. 9.  Rate of formation of PZ using RP or 1,3,4 fraction as an indicator. Optical density 
of unabsorbed 1,3,4,  1.7, of unabsorbed RP 0.940. 
or 1,3,4 fraction. The results are shown in Fig. 9 and indicate that the 1,3,4 fraction makes 
a satisfactory substitute for RP in titrating PZ. 
In this experiment, as well as in all others using the 1,3,4 fraction, no loss 
of C'3 activity was observed on incubating the 1,3,4  fraction with zymosan. 
DISCUSSION 
When  two  substances  interact,  the rate  of reaction generally decreases as 
the concentration of reacting substances becomes smaller. This is true whether 
or not catalysis of the reaction is involved. The fact that the rate curves for 414  PROPERDIN-COMPLEMENT  SYSTEM.  Ii 
the reaction between  zymosan and properdin  show an induction period,  at 
certain  concentrations Of zymosan, indicates that  the  reaction is  complex. 
Experiments  currently in  progress  favor  the  hypothesis that  at  least  two 
consecutive  reactions must occur  prior to the formation of the complex re- 
active with C'3.  Whether this hypothesis is valid or not, the data presented 
in this paper suggest  that considerable  caution should be exercised in inter- 
preting properdin  titrations. 
The substitution of the 1,3,4 fraction for human RP as a  source of C'3 
should make  the  technique for measuring PZ  accessible  to  a  great  many 
laboratories.  The starting material, pig serum,  is inexpensive;  the fractiona- 
tion (5)  is simple; and the fraction itself is stable for months, in the paste 
form, at -5°C. When dissolved, the fraction retains its:activity at 4°C. for 
at least 1 week. A further advantage to be gained, using the 1,3,4 fraction, 
lies in the substitution of EAg.p.C'I.~,~ for its human counterpart. These cells 
are far more stable than EAhuC'A (14) and it is not necessary to pipette them 
in a cold room. 
In the course of this work it was noted that E.D.T.A. treated g,p.C t lysed 
both  EAg.p.C'I.4.~ and EAhuC'A;  E.D.T,A.  treated  1,3,4  fraction  lysed 
only EAg.p:C'I.4.~; and  E.D.T.A.  treated  huC'  lysed  only EAhuC'A.  The 
reasons  for this behavior are somewhat obscure, since the components  of C' 
appear to be, to a considerable extent interchangeable  (15, 16) among the three 
species, and C'3  is presumably the only component active~in the, E.D.T.A.- 
treated material. 
S~ARY 
The  reaction of human, bovine,  and pig  properdin  with excess zymosan 
exhibits  an induction period  followed by a rapidly accelerating  formation of 
the  properdin-zymosan  (PZ)  complex.  Two  methods  for  determining  the 
quantity of PZ complex are given, one using human serum lacking properdin, 
the other using a  fraction of pig serum  containing complement components, 
C'1, C'3 and C'4. 
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